Published in Crit Care Med on April 01, 2012
Health care resource use and costs of two-year survivors of acute lung injury. An observational cohort study. Ann Am Thorac Soc (2015) 1.45
Research as a Standard of Care in the PICU. Pediatr Crit Care Med (2016) 1.44
Use of intensive care services and associated hospital mortality after Massachusetts healthcare reform*. Crit Care Med (2014) 1.43
The inflammatory response in sepsis. Trends Immunol (2012) 1.34
Is there a Starling curve for intensive care? Chest (2012) 1.23
Redefining the gut as the motor of critical illness. Trends Mol Med (2013) 1.15
Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. Science (2015) 1.14
Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J Clin Invest (2016) 1.02
Longitudinal Changes in ICU Admissions Among Elderly Patients in the United States. Crit Care Med (2016) 0.86
Hemoadsorption by CytoSorb in septic patients: a case series. Crit Care (2017) 0.84
Immunopathogenesis of abdominal sepsis. Langenbecks Arch Surg (2014) 0.83
Differential alterations of tissue T-cell subsets after sepsis. Immunol Lett (2015) 0.82
ICU director data: using data to assess value, inform local change, and relate to the external world. Chest (2015) 0.81
Receptor-interacting protein kinase 3 deficiency inhibits immune cell infiltration and attenuates organ injury in sepsis. Crit Care (2014) 0.81
Anti-septic activity of α-cubebenoate isolated from Schisandra chinensis. BMB Rep (2015) 0.81
The immune system's role in sepsis progression, resolution, and long-term outcome. Immunol Rev (2016) 0.78
Expect the unexpected: clinical trials are key to understanding post-intensive care syndrome. Crit Care (2013) 0.75
An extrapolation of Foucault's Technologies of the Self to effect positive transformation in the intensivist as teacher and mentor. Philos Ethics Humanit Med (2013) 0.75
Critical care service in Saudi Arabia. Saudi Med J (2015) 0.75
Does U.S. health care need a national institute of critical care? Crit Care Med (2012) 0.75
Surrogate receptivity to participation in critical illness genetic research: aligning research oversight and stakeholder concerns. Chest (2015) 0.75
Picroside II protects against sepsis via suppressing inflammation in mice. Am J Transl Res (2016) 0.75
Frequency of acute changes found on head computed tomographies in critically ill patients: a retrospective cohort study. J Crit Care (2014) 0.75
Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease. Exp Biol Med (Maywood) (2016) 0.75
Perspectives of Decisional Surrogates and Patients Regarding Critical Illness Genetic Research. AJOB Empir Bioeth (2015) 0.75
Preoperative and surgical factors associated with postoperative intensive care unit admission following operative treatment for degenerative lumbar spine disease. Eur Spine J (2015) 0.75
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37
A randomized trial of protocol-based care for early septic shock. N Engl J Med (2014) 16.05
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39
Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA (2002) 9.89
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care (2006) 9.29
Use of intensive care at the end of life in the United States: an epidemiologic study. Crit Care Med (2004) 9.06
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33
Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A (2003) 7.14
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med (2005) 6.86
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med (2010) 6.69
National estimates of severe sepsis in United States emergency departments. Crit Care Med (2007) 5.99
Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med (2007) 5.65
The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States. Crit Care Med (2004) 5.23
Nighttime intensivist staffing and mortality among critically ill patients. N Engl J Med (2012) 5.22
Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm (2013) 5.02
Variation in critical care services across North America and Western Europe. Crit Care Med (2008) 5.00
The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med (2002) 4.72
Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Crit Care Med (2012) 4.68
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med (2010) 4.64
The effect of multidisciplinary care teams on intensive care unit mortality. Arch Intern Med (2010) 4.41
Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA (2002) 4.09
Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med (2003) 4.04
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA (2013) 3.78
Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A (2002) 3.68
Effectiveness and safety of the awakening and breathing coordination, delirium monitoring/management, and early exercise/mobility bundle. Crit Care Med (2014) 3.46
Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med (2008) 3.44
Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome. Am J Respir Crit Care Med (2012) 3.36
The epidemiology of mechanical ventilation use in the United States. Crit Care Med (2010) 3.28
Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med (2003) 3.18
Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med (2007) 3.17
The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. Crit Care Med (2014) 3.17
Intensive care unit quality improvement: a "how-to" guide for the interdisciplinary team. Crit Care Med (2006) 3.15
Pneumonia: still the old man's friend? Arch Intern Med (2003) 3.12
Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int (2002) 3.07
Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med (2002) 3.02
Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int (2009) 2.97
HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology (2002) 2.95
Estimates of the need for palliative care consultation across united states intensive care units using a trigger-based model. Am J Respir Crit Care Med (2014) 2.95
Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med (2009) 2.93
Organizational characteristics, outcomes, and resource use in 78 Brazilian intensive care units: the ORCHESTRA study. Intensive Care Med (2015) 2.92
Three-year outcomes for Medicare beneficiaries who survive intensive care. JAMA (2010) 2.87
The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med (2006) 2.84
Population burden of long-term survivorship after severe sepsis in older Americans. J Am Geriatr Soc (2012) 2.78
The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med (2012) 2.72
Trends in the epidemiology of pediatric severe sepsis*. Pediatr Crit Care Med (2013) 2.67
Critical care medicine training and certification for emergency physicians. Ann Emerg Med (2005) 2.67
Do intensivist staffing patterns influence hospital mortality following ICU admission? A systematic review and meta-analyses. Crit Care Med (2013) 2.64
End-of-life care for the critically ill: A national intensive care unit survey. Crit Care Med (2006) 2.61
Disability among elderly survivors of mechanical ventilation. Am J Respir Crit Care Med (2010) 2.50
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med (2003) 2.44
Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe. Intensive Care Med (2013) 2.44
Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med (2009) 2.43
Functional Status Scale: new pediatric outcome measure. Pediatrics (2009) 2.42
Prioritizing the organization and management of intensive care services in the United States: the PrOMIS Conference. Crit Care Med (2007) 2.42
Relationship between staff perceptions of hospital norms and hospital-level end-of-life treatment intensity. J Palliat Med (2007) 2.39
Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med (2003) 2.39
Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med (2008) 2.37
Is survival better at hospitals with higher "end-of-life" treatment intensity? Med Care (2010) 2.35
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med (2010) 2.31
Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl (2004) 2.31
Growth of intensive care unit resource use and its estimated cost in Medicare. Crit Care Med (2008) 2.31
Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med (2003) 2.30
Severe sepsis epidemiology: sampling, selection, and society. Crit Care (2004) 2.28
Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA (2010) 2.27
Healthcare costs and long-term outcomes after acute respiratory distress syndrome: A phase III trial of inhaled nitric oxide. Crit Care Med (2006) 2.27
Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med (2006) 2.27
Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy. Cancer (2005) 2.25
Perceptions of safety culture vary across the intensive care units of a single institution. Crit Care Med (2007) 2.24
Variation in use of intensive care for adults with diabetic ketoacidosis*. Crit Care Med (2012) 2.24
Developing a new, national approach to surveillance for ventilator-associated events*. Crit Care Med (2013) 2.24
Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA (2014) 2.23
Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int (2011) 2.22
Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol (2007) 2.12
Posttraumatic stress and complicated grief in family members of patients in the intensive care unit. J Gen Intern Med (2008) 2.12
Critical care medicine training and certification for emergency physicians. Crit Care Med (2005) 2.12
Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med (2005) 2.11
Severe sepsis and septic shock. N Engl J Med (2013) 2.10
Do hospitals provide lower quality of care to black patients for pneumonia? Crit Care Med (2010) 2.07
Targeting mitochondria. Acc Chem Res (2008) 2.03